Kohjin Bio Co., Ltd.
177A.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥8,943 | ¥9,871 | ¥9,871 | ¥11,886 |
| - Cash | ¥3,149 | ¥1,727 | ¥1,463 | ¥1,734 |
| + Debt | ¥2,387 | ¥2,470 | ¥2,100 | ¥2,229 |
| Enterprise Value | ¥8,180 | ¥10,614 | ¥10,509 | ¥12,380 |
| Revenue | ¥5,206 | ¥4,770 | ¥4,743 | ¥3,947 |
| % Growth | 9.1% | 0.6% | 20.2% | – |
| Gross Profit | ¥2,366 | ¥1,881 | ¥2,454 | ¥2,039 |
| % Margin | 45.4% | 39.4% | 51.7% | 51.7% |
| EBITDA | ¥1,406 | ¥958 | ¥1,444 | ¥1,140 |
| % Margin | 27% | 20.1% | 30.5% | 28.9% |
| Net Income | ¥795 | ¥384 | ¥830 | ¥588 |
| % Margin | 15.3% | 8.1% | 17.5% | 14.9% |
| EPS Diluted | 155.52 | 92.2 | 199.23 | 117.18 |
| % Growth | 68.7% | -53.7% | 70% | – |
| Operating Cash Flow | ¥916 | ¥824 | ¥461 | ¥763 |
| Capital Expenditures | -¥887 | -¥563 | -¥561 | -¥204 |
| Free Cash Flow | ¥28 | ¥261 | -¥100 | ¥559 |